Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

Pfizer's forward dividend yield currently stands at 6.86%. This yield is so attractive that I wondered if it's the highest of ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...

Pfizer's diversified pipeline and new product launches are driving operational growth. Click here to read more about PFE ...

Pfizer Inc (NYSE:PFE) recently announced a dividend of $0.41 per share, payable on 2023-12-04, with the ex-dividend date set for 2023-11-08. As investors look forward to this upcoming payment, the ...

A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate PFE stock a Sell.

Pfizer stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just ...

Pfizer's stock price was hammered, but that didn't prevent the company from meeting and raising its dividend commitment. Last December, the pharmaceutical company raised its payout for the 15th ...

Pfizer's dividend payout ratio of 122.5% looks concerning at first glance. A company can only pay out more in dividends than it generates in earnings for a limited time.

For Pfizer to be able to keep paying its dividend, it needs to be profitable and generating enough cash. On Oct. 27, the company reported its third-quarter earnings.

Pfizer’s recent dividend increase is just one of the many reasons to consider buying the company’s shares. 2019 wasn't a great year for Pfizer(PFE 1.49%).